Sandra Therese Antoinette Malkowska

Title: The Innovative Journey of Sandra Therese Antoinette Malkowska

Introduction

Sandra Therese Antoinette Malkowska is a prominent inventor based in Ely, GB. She has made significant contributions to the field of pharmaceuticals, holding a total of five patents. Her work focuses on developing advanced pharmaceutical formulations that enhance the efficacy and delivery of active ingredients.

Latest Patents

Among her latest patents is a groundbreaking pharmaceutical formulation that features a solid, oral controlled release dosage form. This formulation contains a water-soluble active ingredient dispersed in a matrix, which releases the active ingredient at a controlled rate. The median time to reach maximum concentration (tmax) is between 2.5 to 6 hours, with a ratio of mean maximum concentration (Cmax) to mean plasma level of the active ingredient at 24 hours ranging from 1.5 to 3.5. Another notable patent is her controlled release tramadol formulation, which is designed for oral administration and contains tramadol or a pharmaceutically acceptable salt as the active ingredient.

Career Highlights

Throughout her career, Malkowska has worked with reputable companies in the pharmaceutical industry, including Euro-Celtique S.A. and Mundipharma Laboratories GmbH. Her innovative approaches and dedication to research have positioned her as a key player in the development of effective pharmaceutical solutions.

Collaborations

Malkowska has collaborated with esteemed professionals in her field, including Ronald Brown Miller and Stewart Thomas Leslie. These partnerships have further enriched her research and contributed to her success as an inventor.

Conclusion

Sandra Therese Antoinette Malkowska's contributions to pharmaceutical innovations demonstrate her commitment to improving drug delivery systems. Her patents reflect her expertise and dedication to advancing healthcare solutions.